Temporal control of gene deletion in sensory ganglia using a tamoxifen-inducible <it>Advillin-Cre-ERT2 </it>recombinase mouse
<p>Abstract</p> <p>Background</p> <p>Tissue-specific gene deletion has proved informative in the analysis of pain pathways. <it>Advillin </it>has been shown to be a pan-neuronal marker of spinal and cranial sensory ganglia. We generated BAC transgenic mice u...
Main Authors: | Lau Joanne, Minett Michael S, Zhao Jing, Dennehy Ulla, Wang Fan, Wood John N, Bogdanov Yury D |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-12-01
|
Series: | Molecular Pain |
Subjects: | |
Online Access: | http://www.molecularpain.com/content/7/1/100 |
Similar Items
-
Induction of whole-body gene deletion via R26-regulated tamoxifen-inducible Cre recombinase activity
by: Rahul Kumar, et al.
Published: (2022-12-01) -
Generation and characterization of a tamoxifen-inducible lineage tracing tool Cd2-P2A-CreERT2 knock-in mice
by: Yang Guo, et al.
Published: (2025-03-01) -
Comparison of Kindlin-2 deficiency-stimulated osteoarthritis-like lesions induced by Prg4CreERT2 versus AggrecanCreERT2 transgene in mice
by: Qing Yao, et al.
Published: (2023-07-01) -
Into the blue: the importance of murine lacZ gene expression profiling in understanding and treating human disease
by: Chris Armit
Published: (2015-11-01) -
Tamoxifen affects chronic pancreatitis‐related fibrogenesis in an experimental mouse model: an effect beyond Cre recombination
by: Xuan Li, et al.
Published: (2019-10-01)